S&P 500   4,205.45
DOW   33,093.34
QQQ   348.40
10 Ways Entrepreneurs Can Navigate a Down Economy
[BREAKING] New "Living Missile" to Replace Nuclear Missiles (Ad)
Get the Most Out of Remote Meetings and Avoid Meeting Burn Out
A Woman Co-founder's Guide to Empowering Women in the Workplace and Advocating for Gender Equality
66,000% upside on tiny biotech? (Ad)
Open vs. Anonymous Employee Feedback — Which is Better?
PwC Australia sidelines 9 directors as leak of tax information investigated
66,000% upside on tiny biotech? (Ad)
South African president appoints judge to oversee weapons-for-Russia inquiry
Drought-struck Barcelona quenches thirst with costly desalination
S&P 500   4,205.45
DOW   33,093.34
QQQ   348.40
10 Ways Entrepreneurs Can Navigate a Down Economy
[BREAKING] New "Living Missile" to Replace Nuclear Missiles (Ad)
Get the Most Out of Remote Meetings and Avoid Meeting Burn Out
A Woman Co-founder's Guide to Empowering Women in the Workplace and Advocating for Gender Equality
66,000% upside on tiny biotech? (Ad)
Open vs. Anonymous Employee Feedback — Which is Better?
PwC Australia sidelines 9 directors as leak of tax information investigated
66,000% upside on tiny biotech? (Ad)
South African president appoints judge to oversee weapons-for-Russia inquiry
Drought-struck Barcelona quenches thirst with costly desalination
S&P 500   4,205.45
DOW   33,093.34
QQQ   348.40
10 Ways Entrepreneurs Can Navigate a Down Economy
[BREAKING] New "Living Missile" to Replace Nuclear Missiles (Ad)
Get the Most Out of Remote Meetings and Avoid Meeting Burn Out
A Woman Co-founder's Guide to Empowering Women in the Workplace and Advocating for Gender Equality
66,000% upside on tiny biotech? (Ad)
Open vs. Anonymous Employee Feedback — Which is Better?
PwC Australia sidelines 9 directors as leak of tax information investigated
66,000% upside on tiny biotech? (Ad)
South African president appoints judge to oversee weapons-for-Russia inquiry
Drought-struck Barcelona quenches thirst with costly desalination
S&P 500   4,205.45
DOW   33,093.34
QQQ   348.40
10 Ways Entrepreneurs Can Navigate a Down Economy
[BREAKING] New "Living Missile" to Replace Nuclear Missiles (Ad)
Get the Most Out of Remote Meetings and Avoid Meeting Burn Out
A Woman Co-founder's Guide to Empowering Women in the Workplace and Advocating for Gender Equality
66,000% upside on tiny biotech? (Ad)
Open vs. Anonymous Employee Feedback — Which is Better?
PwC Australia sidelines 9 directors as leak of tax information investigated
66,000% upside on tiny biotech? (Ad)
South African president appoints judge to oversee weapons-for-Russia inquiry
Drought-struck Barcelona quenches thirst with costly desalination
Lowest-Rated StocksLowest-Rated
NYSE:PHG

Koninklijke Philips (PHG) Competitors

$19.47
+0.34 (+1.78%)
(As of 05/26/2023 07:00 PM ET)
Compare
Today's Range
$19.39
▼
$19.51
50-Day Range
$16.18
▼
$21.72
52-Week Range
$11.75
▼
$26.05
Volume
766,500 shs
Average Volume
1.79 million shs
Market Capitalization
$17.32 billion
P/E Ratio
N/A
Dividend Yield
4.78%
Price Target
$16.79
ProfileAnalyst RatingsChartCompetitorsDividendEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesOptions ChainSEC FilingsShort InterestSocial Media

PHG vs. HOLX, GEHC, ICLR, BMRN, MOH, COO, LH, STE, RVTY, and EXAS

Should you be buying Koninklijke Philips stock or one of its competitors? The main competitors of Koninklijke Philips include Hologic (HOLX), GE HealthCare Technologies (GEHC), ICON Public (ICLR), BioMarin Pharmaceutical (BMRN), Molina Healthcare (MOH), Cooper Companies (COO), Laboratory Co. of America (LH), STERIS (STE), Revvity (RVTY), and Exact Sciences (EXAS). These companies are all part of the "medical" sector.

Koninklijke Philips vs.

Hologic (NASDAQ:HOLX) and Koninklijke Philips (NYSE:PHG) are both large-cap medical companies, but which is the better business? We will compare the two businesses based on the strength of their dividends, community ranking, earnings, risk, analyst recommendations, valuation, institutional ownership, profitability and media sentiment.

Hologic has higher earnings, but lower revenue than Koninklijke Philips. Koninklijke Philips is trading at a lower price-to-earnings ratio than Hologic, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Hologic$4.86 billion4.00$1.30 billion$2.9926.43
Koninklijke Philips$18.79 billion0.92-$1.69 billion-$2.45-7.95

Hologic currently has a consensus target price of $86.00, indicating a potential upside of 8.82%. Koninklijke Philips has a consensus target price of $16.79, indicating a potential downside of 13.79%. Given Hologic's stronger consensus rating and higher possible upside, analysts plainly believe Hologic is more favorable than Koninklijke Philips.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Hologic
0 Sell rating(s)
8 Hold rating(s)
7 Buy rating(s)
0 Strong Buy rating(s)
2.47
Koninklijke Philips
4 Sell rating(s)
5 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
1.70

Hologic has a net margin of 18.56% compared to Koninklijke Philips' net margin of -11.63%. Hologic's return on equity of 19.39% beat Koninklijke Philips' return on equity.

Company Net Margins Return on Equity Return on Assets
Hologic 18.56% 19.39% 10.57%
Koninklijke Philips -11.63% 6.29% 2.79%

Hologic received 468 more outperform votes than Koninklijke Philips when rated by MarketBeat users. Likewise, 70.01% of users gave Hologic an outperform vote while only 56.99% of users gave Koninklijke Philips an outperform vote.

CompanyUnderperformOutperform
HologicOutperform Votes
831
70.01%
Underperform Votes
356
29.99%
Koninklijke PhilipsOutperform Votes
363
56.99%
Underperform Votes
274
43.01%

In the previous week, Hologic had 3 more articles in the media than Koninklijke Philips. MarketBeat recorded 8 mentions for Hologic and 5 mentions for Koninklijke Philips. Hologic's average media sentiment score of 0.94 beat Koninklijke Philips' score of 0.87 indicating that Hologic is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Hologic
5 Very Positive mention(s)
1 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Koninklijke Philips
3 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Hologic has a beta of 1, suggesting that its share price has a similar volatility profile to the S&P 500.Comparatively, Koninklijke Philips has a beta of 0.91, suggesting that its share price is 9% less volatile than the S&P 500.

95.2% of Hologic shares are held by institutional investors. Comparatively, 10.2% of Koninklijke Philips shares are held by institutional investors. 1.7% of Hologic shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

Summary

Hologic beats Koninklijke Philips on 17 of the 18 factors compared between the two stocks.


New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding PHG and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

PHG vs. The Competition

Export to Excel
MetricKoninklijke PhilipsX IndustryMedical SectorNYSE Exchange
Market Cap$17.32B$14.58B$4.46B$14.41B
Dividend Yield4.75%2.45%6.00%4.08%
P/E Ratio-7.955.2989.2717.40
Price / Sales0.923.333,515.298.92
Price / Cash4.329.1421.8615.13
Price / Book1.242.144.576.91
Net Income-$1.69B$267.20M$115.80M$895.30M
7 Day Performance-3.57%0.45%108.92%-0.90%
1 Month Performance-7.81%-0.95%120.78%-1.35%
1 Year Performance-23.77%-32.29%142.55%-10.16%

Koninklijke Philips Competitors List

Export to Excel
CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
HOLX
Hologic
1.9014 of 5 stars		$80.42
-1.5%		$86.00
+6.9%		+2.0%$19.79B$4.86B26.906,944
GEHC
GE HealthCare Technologies
2.3552 of 5 stars		$77.19
-2.4%		$92.40
+19.7%		N/A$35.10B$18.34B0.0050,000
ICLR
ICON Public
2.9715 of 5 stars		$212.07
-1.8%		$257.30
+21.3%		-10.4%$17.33B$7.74B34.3241,100Positive News
BMRN
BioMarin Pharmaceutical
2.76 of 5 stars		$91.99
-0.8%		$118.65
+29.0%		+9.3%$17.27B$2.10B242.083,082
MOH
Molina Healthcare
2.8031 of 5 stars		$284.85
-1.1%		$354.75
+24.5%		-10.5%$16.61B$31.97B19.4015,000Analyst Downgrade
COO
Cooper Companies
2.3187 of 5 stars		$380.04
-2.6%		$393.30
+3.5%		+4.9%$18.80B$3.31B50.3414,000Upcoming Earnings
Short Interest ↓
LH
Laboratory Co. of America
3.1581 of 5 stars		$218.89
+0.1%		$273.50
+24.9%		-16.4%$19.39B$14.88B19.8680,000
STE
STERIS
2.3619 of 5 stars		$201.88
-2.4%		$226.40
+12.1%		-14.7%$20.04B$4.96B188.6716,422Analyst Revision
RVTY
Revvity
0 of 5 stars		$120.30
+0.0%		N/AN/A$15.09B$3.31B15.6616,700News Coverage
EXAS
Exact Sciences
2.1857 of 5 stars		$82.00
-1.9%		$79.13
-3.5%		+52.3%$14.79B$2.08B-28.086,400Short Interest ↓
Analyst Revision

Related Companies and Tools

Related Companies:
Top 10 Stock Comparisons
This page (NYSE:PHG) was last updated on 5/29/2023 by MarketBeat.com Staff

My Account -